StonvexLoading…
StonvexStonvexStonvexCore line items from RRR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $507.32M | $2.01B | $1.50B | $1.02B |
Operating Income | $143.68M | $597.43M | $453.87M | $322.38M |
Net Income | $42.89M | $188.07M | $143.41M | $101.15M |
EPS (Diluted) | $0.73 | $3.12 | $2.37 | $1.69 |
Total Assets | $4.22B | $4.17B | $4.10B | $4.03B |
Total Liabilities | $3.98B | $3.83B | $3.77B | $3.74B |
Cash & Equivalents | $134.03M | $142.47M | $129.76M | $145.20M |
Free Cash Flow OCF − CapEx | $22.60M | $290.50M | $212.84M | $138.26M |
Shares Outstanding | 59.37M | 102.59M | 102.92M | 103.06M |